CELLINK

CELLINK is at the forefront of biotechnology research, driving innovation and shaping the future of health as a proud member of BICO, the world’s leading bioconvergence company. Since democratizing access to 3D bioprinting with the first universal bioink in 2016, CELLINK has been instrumental in transforming the field into a thriving billion-dollar industry.

CELLINK’s dedication to excellence is reflected in its comprehensive suite of bioinks, bioprinters, software, and services, trusted by leading academics across diverse applications such as 3D cell culturing, tissue engineering, and drug development. CELLINK's innovations have been cited in over 700 publications and are currently utilized in more than 1,000 laboratories, including those within the top 20 pharmaceutical companies.

Located at Arvid Wallgrens Backe 20, Gothenburg, 413 46, SE, and with a presence at 451 D St, Boston, Massachusetts 02210, US, CELLINK is committed to advancing BICO’s bioconvergence revolution, with the ambitious goal of making on-demand bioprinting of human organs and tissues a reality. We invite the management team at CELLINK to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.